GB Patent

GB2515038A — Injection device

Assigned to Cilag GmbH International · Expires 2014-12-17 · 11y expired

What this patent protects

An injection device having a release or locking mechanism, such as a retractable sleeve for pressing against the skin of a user, has tactile and audible feedback signalling means to indicate to a user when the release mechanism is moved from a first position in which injection de…

USPTO Abstract

An injection device having a release or locking mechanism, such as a retractable sleeve for pressing against the skin of a user, has tactile and audible feedback signalling means to indicate to a user when the release mechanism is moved from a first position in which injection delivery is impeded to a second position in which a trigger may be actuated. A variation in the force required to move the release mechanism from the first to the second position, represented by a non-linear profile of force required with distance, may be achieved by resilient arms 201 moving along a curved or undulating camming surface 210 with bumps 212, or by a changing friction surface, or by using a pair of resilient arms or springs. An audible signal may result from contact between components or the completion of an electrical circuit producing an electronic tone, beep or ringing of a bell.

Drugs covered by this patent

Patent Metadata

Patent number
GB2515038A
Jurisdiction
GB
Classification
Expires
2014-12-17
Drug substance claim
No
Drug product claim
No
Assignee
Cilag GmbH International
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.